Bandage Contact Lens Application for the Management of Corneal Abrasion

See also
Status	Clinical Trial	Phase
Withdrawn	`NCT02483897` - Effect of Tetracaine on Pain Management and Corneal Healing in Patients With Acute Corneal Abrasion	Phase 3
Recruiting	`NCT03206723` - Bandage Contact Lenses for Corneal Abrasions	Phase 2
Completed	`NCT04187417` - Short Term Topical Tetracaine is Safe and Highly Efficacious for the Treatment of Pain Caused by Corneal Abrasions	N/A
Not yet recruiting	`NCT05534217` - The Debridement To Treat The Traumatic Corneal Abrasion	N/A

See also

Status

Clinical Trial

Phase

Withdrawn

NCT02483897 - Effect of Tetracaine on Pain Management and Corneal Healing in Patients With Acute Corneal Abrasion

Phase 3

Recruiting

NCT03206723 - Bandage Contact Lenses for Corneal Abrasions

Phase 2

Completed

NCT04187417 - Short Term Topical Tetracaine is Safe and Highly Efficacious for the Treatment of Pain Caused by Corneal Abrasions

N/A

Not yet recruiting

NCT05534217 - The Debridement To Treat The Traumatic Corneal Abrasion

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT04159714
Study type	Interventional
Source	Mayo Clinic
Contact
Status	Terminated
Phase	N/A
Start date	September 10, 2019
Completion date	October 24, 2019

Bandage Contact Lens Application for the Management of Corneal Abrasion

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms